BTIS
HAE icon

BB&T Investment Services’s Haemonetics HAE Stock Holding History

BB&T Investment Services’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$1K Buy
+17
New +$895 ﹤0.01% 1349

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BB&T Investment Services's HAE Position: Q4 2017 in Review

BB&T Investment Services opened a new position in Haemonetics (HAE) in Q4 2017: 17 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1349 among its holdings.

246 funds tracked by Wall St. Rank hold HAE as of Q4 2017.

  • BB&T Investment Services held 17 shares of Haemonetics worth $1K as of Q4 2017.
  • Haemonetics was a new BB&T Investment Services position in Q4 2017.
  • Haemonetics made up ﹤0.01% of BB&T Investment Services's portfolio in Q4 2017, its #1349 holding.
  • 246 funds tracked by Wall St. Rank held Haemonetics as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.